微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -1.03% | -178.38% | 88.96% | 128/157 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | -9.33% | 41.54% | -173.61% | 121/157 | -4.46% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | -3.41% | -274.73% | -12.54% | 121/157 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | -3.03% | -388.71% | 81.02% | 124/157 | 0.3% | 兴齐眼药 | 32.91% | 行业排名> |
| 2024-12-31 | -15.96% | 53.54% | -1653.85% | 126/157 | -9.62% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-09-30 | -0.91% | 93.81% | -46.77% | 117/157 | 4.28% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-06-30 | -0.62% | 94.83% | -67.57% | 118/157 | 2.69% | 百利天恒 | 181.27% | 行业排名> |
| 2024-03-31 | -0.37% | 90.03% | 98.92% | 118/157 | 2.35% | 百利天恒 | 186.1% | 行业排名> |
| 2023-12-31 | -34.35% | -142.58% | -133.51% | 137/157 | -1% | 百利天恒 | 186.89% | 行业排名> |
| 2023-09-30 | -14.71% | -39.43% | -22.58% | 135/157 | 2.36% | 百利天恒 | 188.56% | 行业排名> |
| 2023-06-30 | -12% | -107.61% | -223.45% | 139/157 | 1.48% | 小方制药 | 41.8% | 行业排名> |
| 2023-03-31 | -3.71% | -130.43% | 73.8% | 132/157 | 1.37% | 拓新药业 | 20.51% | 行业排名> |
| 2022-12-31 | -14.16% | -57.68% | -34.22% | 128/157 | 0.79% | 拓新药业 | 19.87% | 行业排名> |
| 2022-09-30 | -10.55% | -25.89% | -82.53% | 127/157 | 2.86% | 拓新药业 | 19.91% | 行业排名> |
| 2022-06-30 | -5.78% | -44.14% | -259.01% | 132/157 | 2.21% | 小方制药 | 55.57% | 行业排名> |
| 2022-03-31 | -1.61% | -26.77% | 82.07% | 124/157 | 1.59% | 福元医药 | 25.41% | 行业排名> |
| 2021-12-31 | -8.98% | 0.11% | -7.16% | 128/157 | 0.84% | 小方制药 | 34.81% | 行业排名> |
| 2021-09-30 | -8.38% | -35.82% | -108.98% | 123/157 | 4.46% | ST人福 | 6.82% | 行业排名> |
| 2021-06-30 | -4.01% | 20.28% | -215.75% | 125/157 | 2.99% | 退市金泰 | 10.74% | 行业排名> |
| 2021-03-31 | -1.27% | 16.99% | 85.87% | 114/157 | 2.49% | 小方制药 | 71.99% | 行业排名> |
| 2020-12-31 | -8.99% | -1422.06% | -45.71% | 118/157 | 3.8% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-09-30 | -6.17% | -408.5% | -22.66% | 106/157 | 3.13% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-06-30 | -5.03% | -404.85% | -228.76% | 119/157 | 4.28% | 哈三联 | 27.17% | 行业排名> |
| 2020-03-31 | -1.53% | -235.4% | -325% | 99/157 | 2.23% | 汇宇制药 | 55.94% | 行业排名> |
| 2019-12-31 | 0.68% | -86.9% | -66% | 114/157 | 2.57% | 中哲精化 | 45.32% | 行业排名> |
| 2019-09-30 | 2% | -61.32% | 21.21% | 93/157 | 7.58% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-06-30 | 1.65% | -59.26% | 46.02% | 89/157 | 5.02% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-03-31 | 1.13% | -54.62% | -78.23% | 81/157 | 2.45% | 奥赛康 | 35% | 行业排名> |
| 2018-12-31 | 5.19% | -59.48% | 0.39% | 85/157 | 7.16% | 奥赛康 | 28.15% | 行业排名> |
| 2018-09-30 | 5.17% | -54.61% | 27.65% | 66/157 | 7.21% | 宏源药业 | 21.91% | 行业排名> |
| 2018-06-30 | 4.05% | -44.75% | 62.65% | 55/157 | 4.63% | 奥赛康 | 9.7% | 行业排名> |
| 2018-03-31 | 2.49% | -29.26% | -80.56% | 42/157 | 2.57% | 奥赛康 | 40.69% | 行业排名> |
| 2017-12-31 | 12.81% | -12.26% | 12.47% | 33/157 | 9.62% | 信立泰 | 25.93% | 行业排名> |
| 2017-09-30 | 11.39% | -2.82% | 55.39% | 20/157 | 8.31% | 昂利康 | 15.91% | 行业排名> |
| 2017-06-30 | 7.33% | 5.77% | 108.24% | 23/157 | 5.56% | 奥赛康 | 12.08% | 行业排名> |
| 2017-03-31 | 3.52% | 9.66% | -75.89% | 16/157 | 2.1% | 一品红 | 31.62% | 行业排名> |
| 2016-12-31 | 14.6% | 11.2% | 24.57% | 36/157 | 6.05% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-09-30 | 11.72% | 8.62% | 69.12% | 18/157 | 5.64% | 中哲精化 | 54.24% | 行业排名> |
| 2016-06-30 | 6.93% | -0.29% | 115.89% | 27/157 | 3.52% | 华东医药 | 7.2% | 行业排名> |
| 2016-03-31 | 3.21% | -1.53% | -75.55% | 25/157 | 2.69% | ST南新 | 81.7% | 行业排名> |